BiogenPatent grantSep 15, 2026

Biogen was granted a patent for anti-VLA-4 antibodies.

What happened

In September 2026 Biogen patented antibody-based compounds designed to bind alpha-4 integrin for potential therapeutic use in medicine.

Source

patents.google.comSep 15, 2026

US patent US12734236

Anti-VLA-4 antibodies

Abstract

This invention relates to alpha-4 binding antibodies, and fragments thereof.

patents.google.com/patent/US12734236Read the full source

Extracted by Autobound

From the Signal API record

Signal: Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date: Sep 15, 2026
Inventors: 3
Patent number: US12734236
Assignee: BIOGEN MA INC.

More patent signals at other companies

PatentsA. O. SmithA. O. Smith Corporation's patent output is accelerating: 9 grants in the past year, 1 in the past 30 days.PatentsSep 29, 2026
PatentsAbbottAbbott Laboratories's patent output is accelerating: 13 grants in the past year, 2 in the past 30 days.PatentsSep 29, 2026
PatentsAbbVieAbbVie Inc.'s patent output is steady: 3 grants in the past year, 0 in the past 30 days.PatentsSep 29, 2026

The full record

From the Signal API record

People

Alexey A. LugovskoyInventor
Frederick R. TaylorInventor
Karen McLachlanInventor

Details

Primary CPC class: A61K 39/39558
USPTO assignee: BIOGEN MA INC.
What the invention does: Antibodies and antibody fragments that attach to VLA-4, a cell-surface protein involved in how immune cells move and interact with tissues.

Topics and mentions

Extraction

Detected: Sep 20, 2026
signal_type: patents-company
signal_subtype: patentGrant

Use this data

Get every patent signal for Biogen and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
MCP setup guide
Send it to your own tools
The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/98303cc8-f4f8-541e-8220-ed5e488d4f81 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.

{
  "signal_id": "98303cc8-f4f8-541e-8220-ed5e488d4f81",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-20T17:32:23+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "cpc": [
      {
        "code": "A61K 39/39558"
      },
      {
        "code": "A61K 45/06"
      },
      {
        "code": "C07K 16/2839"
      },
      {
        "code": "C07K 16/2842"
      },
      {
        "code": "C07K 16/3061"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In September 2026 Biogen patented antibody-based compounds designed to bind alpha-4 integrin for potential therapeutic use in medicine.",
    "summary": "Biogen was granted a patent for anti-VLA-4 antibodies.",
    "event_at": "2026-09-15",
    "inventors": [
      {
        "name": "Alexey A. Lugovskoy",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/alexlugovskoy"
      },
      {
        "name": "Frederick R. Taylor",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Karen McLachlan",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-15",
    "source_url": "https://patents.google.com/patent/US12734236",
    "cpc_primary": {
      "code": "A61K 39/39558"
    },
    "patent_title": "Anti-VLA-4 antibodies",
    "patent_number": "US12734236",
    "uspto_assignee": "BIOGEN MA INC.",
    "patent_abstract": "This invention relates to alpha-4 binding antibodies, and fragments thereof.",
    "precision_class": "structural",
    "invention_explanation": "Antibodies and antibody fragments that attach to VLA-4, a cell-surface protein involved in how immune cells move and interact with tissues.",
    "technologies_mentioned": [
      "antibody therapeutics",
      "alpha-4 integrin",
      "biologics"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/98303cc8-f4f8-541e-8220-ed5e488d4f81 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.